Category Archives: Corporate

The biotechnology industry works to translate life science into solutions for healing previously untreatable medical conditions, feeding the world’s growing population, and fueling mobility and economic growth using cleaner manufacturing processes. These high aspirations have always brought unique challenges to biotechnology companies, and in the wake of the recent worldwide recession those challenges have become particularly difficult. But the need for innovation in health care is clear and present. The number of unmet public health Read More >

Having experienced many election nights as a state legislator and Member of Congress, I still can’t help feeling that nervous excitement that all candidates get as they await the returns. This year was no exception. Though very happy not to have my name on the ballot, I was keenly interested, as I’m sure you were, in the unfolding drama and in what the results would mean for our country and for the future of the Read More >

This morning,U.S. Treasury Secretary Timothy Geithner and HHS Secretary Kathleen Sebelius announced the awardees of the Therapeutic Discovery Project (TDP). The TDP makes available a tax credit to companies with 250 employees or fewer and covers up to 50 percent of qualified investments in projects aimed at creating new therapies, reducing long-term health care costs, or significantly advancing the goal of curing cancer within the next 30 years.  BIO was a strong advocate for the Read More >

Patients are always on our minds at BIO as we work to increase access to safe and effective therapies by advancing policies that support innovation. We all have friends and family members living with chronic conditions or fighting life-threatening diseases, such as cancer, Parkinson’s or ALS. Disease hit close to home recently when a member of the BIO family, Deputy General Counsel for Healthcare Sandi Dennis, was diagnosed with breast cancer. Fortunately, it was caught Read More >

Innovation is one of the things Americans do best and when it comes to creating new therapies, it’s also a key to job growth, strong small businesses, and our industry’s ability to address the needs of patients suffering from debilitating diseases such as cancer, HIV/AIDS and Alzheimer’s. The recently implemented Therapeutic Discovery Project Program offers a tax credit to small biotechnology companies on the cusp of discovering cutting-edge treatments and technologies that will have a Read More >